Rick E. Winningham, Director at Jazz Pharmaceuticals plc (JAZZ), sold 2,178 shares at $152.32 ($332K) on 2022-08-08, disclosed to the SEC on 2022-08-09.
Seasonal sale ($332k) by Director — this insider has traded JAZZ in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $152.32 | 1,089 | $166K | 50.0% |
| 2 | $152.32 | 1,089 | $166K | 50.0% |
| Total | $152.32 avg | 2,178 | $332K | 100% |
| Filing → |
| JAZZ | SELL | 2023-08-15 | $343K | — | Filing → |
| TBPH | SELL | 2022-12-16 | $560K | — | Filing → |
| JAZZ | SELL | 2021-08-10 | $386K | — | Filing → |